SCHEMBL17195429

SCHEMBL17195429

CC(=O)Nc1cc(NC(=O)c2ccc(N3CCCC3)cc2Cl)ccc1Cl

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 7/20 0.62
▸ MEN1 O00255 5/20 0.62
▸ ATM Q13315 1/20 0.62
▸ MAPT P10636 9/20 0.58
▸ RAB9A P51151 6/20 0.58
▸ GAA P10253 2/20 0.58
▸ LMNA P02545 1/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.57
▸ NPC1 O15118 3/20 0.52
▸ KDM4E B2RXH2 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ GLA P06280 1/20 0.50
▸ MCL1 Q07820 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ GFER P55789 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18872992 0.84 KMT2A (0.46) KMT2AMEN1ATMMAPTRAB9A
SCHEMBL17195425 0.83 RAB9A (0.67) KMT2AMEN1ATMMAPTRAB9A
SCHEMBL15683753 0.83 TP53 (0.48) KMT2AMEN1ATMMAPTRAB9A
SCHEMBL15683754 0.79 PKM (0.46) KMT2AMEN1ATMMAPTRAB9A
SCHEMBL15937425 0.76 KMT2A (0.54) KMT2AMEN1ATMMAPTRAB9A
SCHEMBL17333137 0.75 KMT2A (0.53) KMT2AMEN1ATMMAPTRAB9A
Hydrochloric Acid SCHEMBL18045308 0.75 KMT2A (0.95) KMT2AMEN1ATMMAPTRAB9A
SCHEMBL17333153 0.74 CA1 (0.58) KMT2AMEN1ATMMAPTRAB9A
SCHEMBL3791892 0.74 ALDH1A1 (0.60) KMT2AMEN1MAPTSMN1; SMN2ALDH1A1
SCHEMBL15937389 0.74 KMT2A (0.52) KMT2AMEN1ATMMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170135992-A1 CYCLIC SULFONAMIDE CONTAINING DERIVATIVES AS INHIBITORS OF HEDGEHOG SIGNALING PATHWAY NANT HOLDINGS IP, LLC 2017-05-18 — — US disclosed
US-9499539-B2 Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway NANTBIOSCIENCE, INC. (US) 2016-11-22 — — US disclosed
US-20150299190-A1 CYCLIC SULFONAMIDE CONTAINING DERIVATIVES AS INHIBITORS OF HEDGEHOG SIGNALING PATHWAY NANT HOLDINGS IP, LLC 2015-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299190-A1 CYCLIC SULFONAMIDE CONTAINING DERIVATIVES AS INHIBITORS OF HEDGEHOG SIGNALING PATHWAY SMO, SHH, SOS1 KMT2A 2126/4885MEN1 2551/4885ATM 1246/4885
US-20170135992-A1 CYCLIC SULFONAMIDE CONTAINING DERIVATIVES AS INHIBITORS OF HEDGEHOG SIGNALING PATHWAY SMO, SHH, SOS1 KMT2A 2126/4885MEN1 2551/4885ATM 1246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback